In key win, AbbVie lands FDA approval for Allergan's blurred-vision eye drop
AbbVie’s age-related blurry vision drug for aging adults was given the OK by the FDA Friday, making it the first eye …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
